Target intelligence / Profile preview

Senescence associated long non-coding RNA 2 (SALRNA2)

Target
SALRNA2
Molecular classification
Long non-coding RNA (lncRNA), Other (non-coding RNA)
01

Overview

Senescence associated long non-coding RNA 2 (SALRNA2, also known as SAL-RNA2 or XLOC_025931) is a non-coding RNA identified in human fibroblasts that is upregulated during replicative senescence[3]. Functional studies using siRNA-mediated silencing of SALRNA2 in senescent cells result in increased apoptosis and reduced survival, as evidenced by increased levels of cleaved PARP and p53, and a decrease in cell number[3]. This suggests a role for SALRNA2 in protecting the survival of senescent cells, potentially impacting cell aging, tissue homeostasis, and possibly cancer biology. It is not currently considered a classical drug target but may serve as a biomarker for the senescent cell state or for monitoring interventions affecting cell survival during senescence. The specific interacting proteins or regulatory mechanisms remain to be fully elucidated[3].

Other names
SAL-RNA2XLOC_025931
02

Biological functions

Regulation of cellular senescencePromotion of cell survival in senescent cellsModulation of apoptosis[3]
03

Disease associations

Cancer (potential implication in oncogenesis and senescence-related tumor suppression/biology)Aging-associated processes[3]
04

Biomarkers

SALRNA2 upregulation as a marker of cellular senescence (especially in human fibroblasts)[3]

Beyond the preview

Go deeper on Senescence associated long non-coding RNA 2 (SALRNA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senescence associated long non-coding RNA 2 (SALRNA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call